BridgeMD
New treatment option for Epicondylitis, Lateral
Official title Comparison of ESWT and Ultrasound-Guided Ozone Injection in Lateral Epicondylitis
ClinicalTrials.gov ID: NCT07427368
What this study is testing
- What it's testing
- Lateral epicondylitis is a common and often debilitating condition characterized by pain over the lateral aspect of the elbow. Although many patients respond to standard conservative treatments, a subset develops a chronic and treatment-resistant form of the condition.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Age: Male or female patients between 18 and 65 years of age.
- Clinical Diagnosis: Patients diagnosed with lateral epicondylitis, defined by pain in the lateral epicondyle region for more than 3 months, increased...
- Symptom Duration: Presence of symptoms for more than 3 months (resistant cases).
- Treatment Failure: Lack of response to first-line conservative treatments (e.g., analgesics, exercise, rest, splinting).
- Radiographic Confirmation: No other pathology detected on direct radiographs of the elbow.
You likely can't join if
- Elbow Pathology: Presence of elbow problems other than lateral epicondylitis (e.g., loose bodies, rheumatoid nodules).
- Surgical History: History of previous surgery on the affected elbow joint.
- Structural Damage: Presence of tendon rupture.
- Consent: Unwillingness to continue treatment or participate.
- Spinal Pathology: Cervical root pathology (cervical radiculopathy).
- Neuropathy: Diagnosed upper extremity entrapment neuropathy.
See the full eligibility criteria
- Age: Male or female patients between 18 and 65 years of age.
- Clinical Diagnosis: Patients diagnosed with lateral epicondylitis, defined by pain in the lateral epicondyle region for more than 3 months, increased pain on palpation of the lateral epicondyle, and positive provocation...
- Symptom Duration: Presence of symptoms for more than 3 months (resistant cases).
- Treatment Failure: Lack of response to first-line conservative treatments (e.g., analgesics, exercise, rest, splinting).
- Radiographic Confirmation: No other pathology detected on direct radiographs of the elbow.
- Injection History: No corticosteroid injection to the affected elbow within the last 6 months.
- Consent: Voluntary participation in the study
- Elbow Pathology: Presence of elbow problems other than lateral epicondylitis (e.g., loose bodies, rheumatoid nodules).
- Surgical History: History of previous surgery on the affected elbow joint.
- Structural Damage: Presence of tendon rupture.
- Consent: Unwillingness to continue treatment or participate.
- Spinal Pathology: Cervical root pathology (cervical radiculopathy).
- Neuropathy: Diagnosed upper extremity entrapment neuropathy.
- Neurological Status: Presence of neurological impairment or deficits.
- Recent Injections: History of injection therapy to the elbow within the last 6 months.
- Recent Therapy: History of physical therapy for the elbow region within the last 6 months.
- Pregnancy: Pregnant women.
- Hematological: Presence of coagulation or bleeding disorders.
- Vascular: Presence of peripheral vasculopathy.
- Pain Syndromes: Presence of Complex Regional Pain Syndrome (CRPS).
- Oncology: History of malignancy.
- Systemic Diseases: Presence of systemic inflammatory or autoimmune disorders (e.g., Rheumatoid Arthritis, SLE).
- Trauma: History of direct trauma to the elbow.
- Medication: Current use of medications that may affect pain levels or muscle strength (e.g., muscle relaxants, analgesics, gabapentinoids).
- Local Infection: Presence of open wounds, infection, or signs of active inflammation in the elbow region.
- Cooperation: Difficulty in cooperation or cognitive inability to follow instructions.
- Enzyme Deficiency: Congenital Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency.
The study team makes the final eligibility decision.
Where it's taking place
- Ankara, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ankara, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.